MBX MBX Biosciences, Inc.
Company Analysis
Latest News
🟢 MBX Biosciences is trading 5.3% up
MBX Biosciences is trading at $61.40, up 5.3% from a comparison close of $58.30 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 5.0% down
MBX Biosciences is trading at $57.26, down 5.0% from a comparison close of $60.28 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 4.2% down today following a downgrade to "Sell" by Wall Street Zen
MBX Biosciences is trading at $60.27 (down 4.2%) today. The decline follows a downgrade by Wall Street Zen from a "hold" to a "sell" rating issued on...
🟢 MBX Biosciences is trading 4.2% up today on company-specific rebound and pipeline optimism
MBX Biosciences is trading 4.2% up today at $60.77 as shares rebound from recent biotech sector volatility and risk-off pressure. • The move appears to be a...
🔴 MBX Biosciences is trading 4.2% down today on risk-off sentiment hitting the biotech sector
MBX Biosciences is trading 4.2% down at $58.15 as broader pressure on biotech and growth stocks weighs on the share price. • The move comes despite a lack of...
🟢 MBX Biosciences is trading 5.2% up
MBX Biosciences is trading at $59.55, up 5.2% from a comparison close of $56.59 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 10.5% down today amid broader biotech sector pressure
MBX Biosciences is trading at $53.99 (-10.48%) as the stock faces a sharp selloff driven by broader weakness in the biotechnology industry. • The move appears...
🔴 MBX Biosciences is trading 13.1% down
MBX Biosciences is trading at $52.19, down 13.1% from a comparison close of $60.04 during pre-market. This is a price-action follow-up, so a separate catalyst...
🔴 MBX Biosciences is trading 5.9% down today after announcing a major executive leadership transition
MBX Biosciences is trading 5.9% down at $56.52 following the announcement of a major executive leadership transition effective immediately. • The Board has...
MBX Biosciences Appoints New CEO and CFO in Major Leadership Transition
MBX Biosciences announced a significant leadership transition, with CEO Kent P. Hawryluk stepping down effective July 13, 2026. The company has appointed its...
🔴 MBX Biosciences is trading 10.0% down
MBX Biosciences is trading at $54.02, down 10.0% from a comparison close of $60.04 during after-hours. This is a price-action follow-up, so a separate catalyst...
🔴 MBX Biosciences is trading 8.3% down today on profit-taking and sector weakness
MBX Biosciences is trading at $55.05 (8.3% down) as investors lock in gains following an extended multi-month rally. • The pullback is driven by...
🔴 MBX Biosciences is trading 6.3% down today on profit-taking and sector-wide weakness
MBX Biosciences is trading 6.3% down at $57.22 as the stock continues to consolidate following a massive multi-month rally and recent profit-taking. • Recent...
MBX Biosciences Pulls Back 6% After a Monster Rally — Can the Science Justify a $3 Billion Valuation With Zero Revenue?
Shares of MBX Biosciences slid 6.4% to $61.50 on July 10, erasing much of the prior session's surge to an all-time high, with no new company-specific news...
🔴 MBX Biosciences is trading 6.4% down today after profit-taking following June hypoparathyroidism data
MBX Biosciences is trading at $61.50 (-6.41%) today as the stock undergoes a sharp pullback following a recent rally tied to clinical data. • The stock's...
🟢 MBX Biosciences is trading 5.3% up today after favorable coverage of chronic hypoparathyroidism study data
MBX Biosciences is trading at $65.03 (5.3% up) today, extending a strong upward trend since late June following favorable coverage of study data in chronic...
🟢 MBX Biosciences, Inc. is trading 4.07% up
MBX is trading at $60.05, up 4.07%.
🟢 MBX extends move to 5.4% up
MBX is trading at $58.16, up 5.4% versus the comparison close of $55.20 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MBX Surges 4.2% Following Paradigm Biocapital Stake Acquisition and Strong Analyst Sentiment
MBX is trading at $57.54 (4.2% up) today, driven by recent news of Paradigm Biocapital Advisors LP's significant stake acquisition and positive analyst...
🟢 MBX extends move to 5.2% up
MBX is trading at $56.66, up 5.2% versus the comparison close of $53.85 during regular trading. This is a price-movement alert; no separate company-specific...